IRD Q3 2021 Earnings — Opus Genetics, Inc. Revenue & Financial Results | Market Cap Arena

IRDOpus Genetics, Inc.

$346M

Q3 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$489,000

Gross Profit

$489,000100.0% margin

Operating Income

-$4M-865.4% margin

Net Income

-$4M-865.0% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+389.0%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$478,000

Balance Sheet

Total Assets

$23M

Total Liabilities

$3M

Stockholders' Equity

$21M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$489,000	$0	—
Gross Profit	$489,000	$0	—
Operating Income	-$4M	-$2M	-117.2%
Net Income	-$4M	-$1M	-238.9%